➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: August 14, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Chlorthalidone, and when can generic versions of Chlorthalidone launch?

Chlorthalidone is a drug marketed by Abbott, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms Inc, Arise, Ascot, Barr Labs Inc, Cosette, Dava Pharms Inc, Ivax Pharms, Kv Pharm, Mutual Pharm, Mylan, Pioneer Pharms, Purepac Pharm, Riconpharma Llc, Sandoz, Sun Pharm Industries, Superpharm, Umedica Labs Pvt Ltd, Unichem Labs Ltd, Usl Pharma, Vangard, Vistapharm, Warner Chilcott, Watson Labs, and Zydus Pharms. and is included in fifty-one NDAs.

The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

US ANDA Litigation and Generic Entry Outlook for Chlorthalidone

A generic version of CHLORTHALIDONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.

  Start Trial

Drug patent expirations by year for CHLORTHALIDONE

See drug prices for CHLORTHALIDONE

Drug Sales Revenue Trends for CHLORTHALIDONE

See drug sales revenues for CHLORTHALIDONE

Recent Clinical Trials for CHLORTHALIDONE

Identify potential brand extensions & 505(b)(2) entrants

Instituto de Cardiologia do Rio Grande do SulPhase 3
Hospital General de México Dr. Eduardo LiceagaPhase 4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2

See all CHLORTHALIDONE clinical trials

Pharmacology for CHLORTHALIDONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for CHLORTHALIDONE

US Patents and Regulatory Information for CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Superpharm CHLORTHALIDONE chlorthalidone TABLET;ORAL 087473-001 Feb 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Purepac Pharm CHLORTHALIDONE chlorthalidone TABLET;ORAL 088139-001 Jul 16, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Vangard CHLORTHALIDONE chlorthalidone TABLET;ORAL 088012-001 Jul 14, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms CHLORTHALIDONE chlorthalidone TABLET;ORAL 207813-001 May 10, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.